SII confident of getting EMA's approval for Covishield in a month, says Adar Poonawalla3 min read . Updated: 01 Jul 2021, 07:40 AM IST
- The Serum Institute CEO also said that the issue of vaccine passports should be on the basis of reciprocity between the countries
The Covishield vaccine produced by the Serum Institute of India and developed by AstraZeneca and Oxford University will receive approval from the European Medicines Agency (EMA) in a month, SII's chief executive officer Adar Poonawalla said on Wednesday.
Select your Category